Novel environment and GABA agonists alter event-related potentials in N-methyl-D-aspartate NR1 hypomorphic and wild-type mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 331, Issue 1, 2009, Pages 308-318

  Bodarky, Christina L ^a   Halene, Tobias B ^a,b   Ehrlichman, Richard S ^a   Banerjee, Anamika ^a   Ray, Rabindranath ^a   Hahn, Chang Gyu ^a   Jonak, Gerald ^c   Siegel, Steven J ^a,b,d  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c ASTRAZENECA   (United Kingdom)

^d Translational Research Laboratories   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; BACLOFEN; CHLORDIAZEPOXIDE; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1;

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; EVOKED AUDITORY RESPONSE; GENOTYPE; HABITUATION; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHIZOPHRENIA; WESTERN BLOTTING;

ACOUSTIC STIMULATION; ANIMALS; EVOKED POTENTIALS, AUDITORY; EXPLORATORY BEHAVIOR; FEMALE; GABA AGONISTS; GABA-A RECEPTOR AGONISTS; HABITUATION, PSYCHOPHYSIOLOGIC; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; RECEPTORS, GABA-A; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 70349312562     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.150938     Document Type: Article

References (40)

1. Bickel S, Lipp HP, and Umbricht D (2008) Early auditory sensory processing deficits in mouse mutants with reduced NMDA receptor function. Neuropsychopharmacology 33:1680-1689. (Pubitemid 351684705)
2. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254.
3. Chen QX and Wong RK (1995) Suppression of GABAA receptor responses by NMDA application in hippocampal neurones acutely isolated from the adult guinea-pig. J Physiol (Lond) 482:353-362.
4. Clementz BA and Blumenfeld LD (2001) Multichannel electroencephalographic assessment of auditory evoked response suppression in schizophrenia. Exp Brain Res 139:377-390. (Pubitemid 32703944)
5. Connolly PM, Maxwell C, Liang Y, Kahn JB, Kanes SJ, Abel T, Gur RE, Turetsky BI, and Siegel SJ (2004) The effects of ketamine vary among inbred mouse strains and mimic schizophrenia for the P80, but not P20 or N40 auditory ERP components. Neurochem Res 29:1179-1188. (Pubitemid 39023492)
6. Connolly PM, Maxwell CR, Kanes SJ, Abel T, Liang Y, Tokarczyk J, Bilker WB, Turetsky BI, Gur RE, and Siegel SJ (2003) Inhibition of auditory evoked potentials and prepulse inhibition of startle in DBA/2J and DBA/2Hsd inbred mouse substrains. Brain Res 992:85-95. (Pubitemid 37356998)
7. Curran HV, Pooviboonsuk P, Dalton JA, and Lader MH (1998) Differentiating the effects of centrally acting drugs on arousal and memory: an event-related potential study of scopolamine, lorazepam and diphenhydramine. Psychopharmacology (Berl) 135:27-36. (Pubitemid 28055447)
8. Duncan GE, Moy SS, Perez A, Eddy DM, Zinzow WM, Lieberman JA, Snouwaert JN, and Koller BH (2004) Deficits in sensorimotor gating and tests of social behavior in a genetic model of reduced NMDA receptor function. Behav Brain Res 153:507-519. (Pubitemid 38953128)
9. Farber NB (2003) The NMDA receptor hypofunction model of psychosis. Ann N Y Acad Sci 1003:119-130.
10. Freedman R, Adler LE, Waldo MC, Pachtman E, and Franks RD (1983) Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia: comparison of medicated and drug-free patients. Biol Psychiatry 18:537-551. (Pubitemid 13135325)
11. Gasior M, Kaminski R, and Witkin JM (2004) Pharmacological modulation of GABA(B) receptors affects cocaine-induced seizures in mice. Psychopharmacology (Berl) 174:211-219. (Pubitemid 38916294)
12. Gonzalez-Burgos G and Lewis DA (2008) GABA neurons and the mechanisms of network oscillations: implications for understanding cortical dysfunction in schizophrenia. Schizophr Bull 34:944-961.
13. Halene TB, Ehrlichman RS, Liang Y, Christian EP, Jonak GJ, Gur TL, Blendy JA, Dow HC, Brodkin ES, Schneider F, et al. (2009) Assessment of NMDA receptor NR1 subunit hypofunction in mice as a model for schizophrenia. Genes Brain Behav, doi:10.1111/j.1601-183X.2009.00504.x.
14. Halene TB and Siegel SJ (2008) Antipsychotic-like properties of phosphodiesterase 4 inhibitors: evaluation of 4-(3-butoxy-4-methoxybenzyl)-2- imidazolidinone (R0-20-1724) with auditory event-related potentials and prepulse inhibition of startle. J Pharmacol Exp Ther 326:230-239.
15. Hashimoto T, Bazmi HH, Mirnics K, Wu Q, Sampson AR, and Lewis DA (2008) Conserved regional patterns of GABA-related transcript expression in the neocortex of subjects with schizophrenia. Am J Psychiatry 165:479-489. (Pubitemid 351694291)
16. Hernández LF, Segovia G, and Mora F (2003) Effects of activation of NMDA and AMPA glutamate receptors on the extracellular concentrations of dopamine, acetylcholine, and GABA in striatum of the awake rat: a microdialysis study. Neurochem Res 28:1819-1827. (Pubitemid 37444678)
17. Jansen LM, Gispen-de Wied CC, and Kahn RS (2000) Selective impairments in the stress response in schizophrenic patients. Psychopharmacology (Berl) 149:319-325. (Pubitemid 30262347)
18. Javitt DC and Zukin SR (1991) Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry 148:1301-1308.
19. Jin Y, Potkin SG, Patterson JV, Sandman CA, Hetrick WP, and Bunney WE Jr (1997) Effects of P50 temporal variability on sensory gating in schizophrenia. Psychiatry Res 70:71-81. (Pubitemid 27245156)
20. B receptors in regulation of transmitter release in cerebellar granule neurons. J Neurosci Res 39:646-655.
21. Kendler KS, Walters EE, Neale MC, Kessler RC, Heath AC, and Eaves LJ (1995) The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and alcoholism. Arch Gen Psychiatry 52:374-383.
22. Lahti AC, Weiler MA, Tamara Michaelidis BA, Parwani A, and Tamminga CA (2001) Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology 25:455-467. (Pubitemid 32830950)
23. Lewis DA, Cho RY, Carter CS, Eklund K, Forster S, Kelly MA, and Montrose D (2008a) Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia. Am J Psychiatry 165:1585-1593.
24. Lewis DA, Hashimoto T, and Morris HM (2008b) Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia. Neurotox Res 14:237-248.
25. Lowy MT, Gault L, and Yamamoto BK (1993) Adrenalectomy attenuates stress-induced elevations in extracellular glutamate concentrations in the hippocampus. J Neurochem 61:1957-1960. (Pubitemid 23317225)
26. Majewski-Tiedeken CR, Rabin CR, and Siegel SJ (2008) Ketamine exposure in adult mice leads to increased cell death in C3H, DBA2 and FVB inbred mouse strains. Drug Alcohol Depend 92:217-227.
27. Maxwell CR, Ehrlichman RS, Liang Y, Gettes DR, Evans DL, Kanes SJ, Abel T, Karp J, and Siegel SJ (2006a) Corticosterone modulates auditory gating in mouse. Neuropsychopharmacology 31:897-903.
28. Maxwell CR, Ehrlichman RS, Liang Y, Trief D, Kanes SJ, Karp J, and Siegel SJ (2006b) Ketamine produces lasting disruptions in encoding of sensory stimuli. J Pharmacol Exp Ther 316:315-324. (Pubitemid 41832611)
29. Moghaddam B, Bolinao ML, Stein-Behrens B, and Sapolsky R (1994) Glucocorticoids mediate the stress-induced extracellular accumulation of glutamate. Brain Res 655:251-254. (Pubitemid 24263017)
30. Mohn AR, Gainetdinov RR, Caron MG, and Koller BH (1999) Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell 98:427-436.
31. Norman RM and Malla AK (1993) Stressful life events and schizophrenia. I: a review of the research. Br J Psychiatry 162:161-166. (Pubitemid 23041391)
32. Piazza PV and Le Moal M (1998) The role of stress in drug self-administration. Trends Pharmacol Sci 19:67-74.
33. Ray PG, Meador KJ, and Loring DW (1992) Diazepam effects on the P3 event-related potential. J Clin Psychopharmacol 12:415-419.
34. Rodgers RJ, Davies B, and Shore R (2002) Absence of anxiolytic response to chlordiazepoxide in two common background strains exposed to the elevated plus-maze: importance and implications of behavioural baseline. Genes Brain Behav 1:242-251. (Pubitemid 36717670)
35. Schiffer WK, Logan J, and Dewey SL (2003) Positron emission tomography studies of potential mechanisms underlying phencyclidine-induced alterations in striatal dopamine. Neuropsychopharmacology 28:2192-2198. (Pubitemid 37468187)
36. Siegel SJ, Connolly P, Liang Y, Lenox RH, Gur RE, Bilker WB, Kanes SJ, and Turetsky BI (2003) Effects of strain, novelty, and NMDA blockade on auditory-evoked potentials in mice. Neuropsychopharmacology 28:675-682.
37. Smolders I, De Klippel N, Sarre S, Ebinger G, and Michotte Y (1995) Tonic GABA-ergic modulation of striatal dopamine release studied by in vivo microdialysis in the freely moving rat. Eur J Pharmacol 284:83-91.
38. White PM and Yee CM (1997) Effects of attentional and stressor manipulations on the P50 gating response. Psychophysiology 34:703-711.
39. Yee CM and White PM (2001) Experimental modification of P50 suppression. Psychophysiology 38:531-539.
40. Zukin RS and Bennett MV (1995) Alternatively spliced isoforms of the NMDARI receptor subunit. Trends Neurosci 18:306-313.